Delivery Order SPE2DB24D1021-SPE2DB24FEUEW

Award Date 9/20/24
Potential Completion Date 9/23/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CLINDAMYCIN 900 MG/50 ML-D5W 50ML, a medical commodity, with a ceiling value of $4,818.32. The contract is a Firm Fixed Price type, with a period of performance through February 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of CLINDAMYCIN 600 MG/50 ML-D5W 50ML, a pharmaceutical product. The contract is not set aside and has a ceiling value of $2,599.76. The ultimate completion date is June 12, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 900 mg/50 mL clindamycin antibiotic medication, with a ceiling value of $14,288.28 and a completion date of January 31, 2025. The contract is a firm fixed price type and is not set aside for any specific business designation. AmerisourceBergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of clindamycin 900 mg/50 ml in 50 ml bags. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,563.82 and a period of performance through April 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of a specific pharmaceutical product - Clindamycin 900 mg/50 ml-D5W 50 ml. The contract has a firm fixed price of $3,734.82 and a period of performance through June 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of CLINDAMYCIN 600 MG/50 ML-D5W 50ML, a pharmaceutical product, with a ceiling value of $4,381.82 and a period of performance through March 31, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $2,433.96 firm fixed-price contract is for the supply of Clindamycin 900 mg/50 mL-D5W 50 mL, a critical care medication. The contract has an ultimate completion date of September 16, 2024 and does not have a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,920.33, is for the supply of Clindamycin 900 mg/50 ml-D5W 50 ml, a prescription antibiotic medication. The contract is a firm-fixed-price delivery order with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...
This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,277.84 award is for the supply of CLINDAMYCIN 900 MG/50 ML-D5W 50ML, a pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp, operating out of Conshohocken, Pennsylvania, is the prime contractor on this delivery order, which does not have a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,478.88 firm fixed-price delivery order is for the supply of CLINDAMYCIN 900 MG/50 ML-D5W 50ML, with a period of performance through November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB24FEUEW
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Clindamycin 900 mg/50 ml-D5W 50 ml. The order has a ceiling value of $1,253.68 and a completion date of September 23, 2024. This is not a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a wide range of medical commodities to support military treatment programs and facilities worldwide. The company has extensive experience in supplying critical pharmaceutical products and medical supplies to various federal agencies, including the Department of Justice Federal Bureau of Investigation.

Generated 12/20/24, 9:17 AM